Trial Profile
Phase I Feasibility Study of Clofarabine and Low Dose Total Body Irradiation (TBI) as a Non-Myeloablative Preparative Regimen for Stem Cell Transplantation (SCT) for Hematologic Malignancies: a Multi-Center Study.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Feb 2024
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary) ; Ciclosporin; Mycophenolate mofetil
- Indications Acute myeloid leukaemia; Graft-versus-host disease; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 17 May 2015 Status changed from suspended to completed as per ClinicalTrials.gov record.
- 17 May 2015 Status changed from suspended to completed as per ClinicalTrials.gov record.
- 25 May 2010 Status changed from not yet recruiting to recruiting as reported by Vanderbilt-Ingram Cancer Center record.